Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | ALX2004 |
| Synonyms | |
| Therapy Description |
Limited information is currently available on ALX2004, a putative antibody-drug conjugate (ADC) targeting EGFR (Jul 2025). |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| ALX2004 | ALX 2004|ALX-2004 | EGFR Antibody 72 | Limited information is currently available on ALX2004, a putative antibody-drug conjugate (ADC) targeting EGFR (Jul 2025). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|---|---|---|---|---|---|
| NCT07085091 | Phase I | ALX2004 | A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors | Recruiting | USA | 0 |